Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Temperature excursions

The product was stored or shipped outside its labeled temperature range. Heat or freezing can degrade a drug without any visible change, so it may be weaker than labeled.

569 FDA drug recalls with this cause, newest first.

Vaccines, insulin, many injectables and some tablets must stay within a narrow temperature band from factory to pharmacy. A truck without working refrigeration, a freezer failure or a warehouse heatwave is enough: the product looks normal but may have lost potency or formed degradation products. FDA files these under 'CGMP deviations' or 'temperature abuse'; we track them separately because the question to ask - how was my medication stored? - is different from every other cause.

Total recalls
569
Class I (high risk)
16
Currently ongoing
135
Most recent
Jun 10, 2026

Most-cited firms for this cause

  • Cardinal Health Inc.206
  • Mckesson Medical-Surgical Inc. Corporate Office137
  • Family Dollar Stores, Llc.117
  • Cardinal Healthcare42
  • Novo Nordisk Inc13
  • Fresenius Medical Care Holdings, Inc.8
  • Daiichi Sankyo Pharma Development8
  • Sandoz Inc4
Class II · Moderate risk

Gemcitabine Injection

Temperature Abuse: Product was stored incorrectly in a controlled room temperature environment instead of a refrigerated environment.

Ongoing Temperature excursion McKesson D-0714-2026
Class I · High risk

Udenyca

Temperature Abuse. 116 cartons with specific serial numbers of Lot 2199821, were stored incorrectly in a controlled room temperature environment instead of the required refrigerated environment.

Ongoing Temperature excursion McKesson NDC 69448-025-63 D-0353-2026
Class II · Moderate risk

Recombinate

CGMP Deviations - Product was exposed to temperatures outside the product's labeled storage requirements.

Ongoing Temperature excursion Cardinal Health Inc. D-0573-2025
Class II · Moderate risk

Xolair (omalizumab injection)

CGMP Deviations - Product was exposed to temperatures outside the product's labeled storage requirements.

Ongoing Temperature excursion Cardinal Health Inc. NDC 50242-214-55 D-0572-2025
Class II · Moderate risk

Infuvite Adult

Severe thunderstorms caused transit delays of certain cold chain products that were shipped on 02-Apr-2025 and delivered after the 48-hours specified delivery time, on 07-Apr-2025 and 08-Apr-2025. The affected products may not have been stored at the recommended labeled storage conditions which may have impacted the safety, quality, identity, potency and purity of the product.

Ongoing Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 54643-5649-1 D-0401-2025
Class II · Moderate risk

Medroxyprogesterone Acetate Injectable Suspension

Severe thunderstorms caused transit delays of certain cold chain products that were shipped on 02-Apr-2025 and delivered after the 48-hours specified delivery time, on 07-Apr-2025 and 08-Apr-2025. The affected products may not have been stored at the recommended labeled storage conditions which may have impacted the safety, quality, identity, potency and purity of the product.

Ongoing Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 55150-0330-01 D-0400-2025
Class II · Moderate risk

BENLYSTA (belimumab)

CGMP Deviations; potential temperature excursions due to transit delays

Ongoing Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 49401-102-01 D-0540-2025
Class II · Moderate risk

Evenity

CGMP Deviations; potential temperature excursions due to transit delays

Ongoing Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 55513-880-02 D-0539-2025
Class II · Moderate risk

PROLIA (denosumab)

CGMP Deviations; potential temperature excursions due to transit delays

Ongoing Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 55513-710-21 D-0538-2025
Class II · Moderate risk

Wegovy (semaglutide)

Temperature abuse: Wegovy product was potentially exposed to temperatures outside of the products labeled storage conditions due to a shipping error involving a Cardinal Health distribution center. More specifically, product was removed from refrigerated storage for an extended period of time and inappropriately released.

Ongoing Temperature excursion Cardinal Health Inc. NDC 0169-4524-14 D-0393-2025
Class II · Moderate risk

Hylenex recombinant

cGMP Deviations: Temperature excursion

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 18657-117-04 D-0116-2025
Class II · Moderate risk

Terlivaz (terlipressin for injection)

cGMP deviations: Temperature excursion due to shipping delay from manufacturer to distributor. Affected distributor has been notified.

Ongoing Temperature excursion Mallinckrodt Hospital Products Inc. NDC 43825-200-01 D-0341-2024
Class II · Moderate risk

Acthar Gel

cGMP deviations: Temperature excursion due to shipping delay from manufacturer to distributor. Affected distributor has been notified.

Ongoing Temperature excursion Mallinckrodt Hospital Products Inc. NDC 63004-8710-1 D-0340-2024
Class II · Moderate risk

All Over-The-Counter

CGMP Deviations: Potential exposure to rodents and rodent activity in the distribution center. Also, due to unusually hot weather, FDA Recalled Products may have been subjected to temperatures in excess of storage condition instructions on product labeling.

Ongoing Temperature excursion Inmar Supply Chain Solutions, LLC D-1104-2023